- Home
- TXMD vs BRN Comparison
TXMD vs BRN Comparison
Compare TXMD & BRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TXMD
- BRN
- Stock Information
- Founded
- TXMD 2008
- BRN 1956
- Country
- TXMD United States
- BRN United States
- Employees
- TXMD N/A
- BRN N/A
- Industry
- TXMD Biotechnology: Pharmaceutical Preparations
- BRN Oil & Gas Production
- Sector
- TXMD Health Care
- BRN Energy
- Exchange
- TXMD Nasdaq
- BRN Nasdaq
- Market Cap
- TXMD 12.7M
- BRN 11.4M
- IPO Year
- TXMD N/A
- BRN N/A
- Fundamental
- Price
- TXMD $1.06
- BRN $1.17
- Analyst Decision
- TXMD
- BRN
- Analyst Count
- TXMD 0
- BRN 0
- Target Price
- TXMD N/A
- BRN N/A
- AVG Volume (30 Days)
- TXMD 17.5K
- BRN 29.6K
- Earning Date
- TXMD 11-11-2025
- BRN 08-13-2025
- Dividend Yield
- TXMD N/A
- BRN N/A
- EPS Growth
- TXMD N/A
- BRN N/A
- EPS
- TXMD N/A
- BRN N/A
- Revenue
- TXMD $2,559,000.00
- BRN $18,073,000.00
- Revenue This Year
- TXMD $427.09
- BRN N/A
- Revenue Next Year
- TXMD N/A
- BRN N/A
- P/E Ratio
- TXMD N/A
- BRN N/A
- Revenue Growth
- TXMD 156.93
- BRN N/A
- 52 Week Low
- TXMD $0.70
- BRN $1.08
- 52 Week High
- TXMD $2.44
- BRN $2.40
- Technical
- Relative Strength Index (RSI)
- TXMD 40.43
- BRN 54.94
- Support Level
- TXMD $1.06
- BRN $1.08
- Resistance Level
- TXMD $1.14
- BRN $1.19
- Average True Range (ATR)
- TXMD 0.05
- BRN 0.06
- MACD
- TXMD -0.00
- BRN 0.00
- Stochastic Oscillator
- TXMD 5.26
- BRN 42.86
About TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.
About BRN Barnwell Industries Inc.
Barnwell Industries Inc is an oil and gas firm. Its areas of operations include acquiring, developing, producing, and selling oil and natural gas. The company acquires and develops crude oil and natural gas assets. The company's operating segment includes Oil and natural gas, Contract drilling, Land investment, and Others. It generates maximum revenue from the Oil and natural gas segment. It operates in two geographical segments the United States, which generates a majority of revenue, and Canada.